ey0016.10-4 | (1) | ESPEYB16
Rawshani Araz
, Sattar Naveed
, Franzen Stefan
, Rawshani Aidin
, Hattersley Andrew T
, Svensson Ann-Marie
, Eliasson Bjorn
, Gudbjornsdottir Soffia
To read the full abstract: Lancet 218; 392: 451530Despite great improvements in diabetes care, people with type 1 diabetes (T1D) remain at increased risk of mortality and morbidity, in particular from cardiovascular disease (CVD). How exactly diabetes leads to CVD and which factors contribute to the increased risk profile is still largely unknown. Molecular mechanisms are being stu...